Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

We designed a new treatment protocol incorporating concurrent administration of L-asparaginase (to reduce the probability of systemic progression during concurrent chemoradiotherapy (CCRT)) plus high-dose methotrexate to consolidation chemotherapy to intensify the regimen for treating localized extr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Dok Hyun, Kim, Seok Jin, Jeong, Seong Hyun, Shin, Dong-Yeop, Bae, Sung Hwa, Hong, Junshik, Park, Seong Kyu, Yhim, Ho-Young, Yang, Deok-Hwan, Lee, Hyewon, Kang, Hye Jin, Lee, Mark Hong, Eom, Hyeon-Seok, Kwak, Jae-Yong, Lee, Jae Hoon, Suh, Cheolwon, Kim, Won Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356760/
https://www.ncbi.nlm.nih.gov/pubmed/27542213
http://dx.doi.org/10.18632/oncotarget.11319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356760/
https://www.ncbi.nlm.nih.gov/pubmed/27542213
http://dx.doi.org/10.18632/oncotarget.11319

Ejemplares similares